Prostate cancer has recently been recognized as a genomically heterogeneous disease with subtypes similar to breast or ovarian cancers.  Read more read more →

Delivering radiation in a shorter time frame significantly reduced the chance of prostate cancer returning in men with an intermediate-risk form of the disease, a study found. Read more read more →

Using the Prostate Health Index test to help diagnose prostate cancer significantly reduces unnecessary and expensive biopsies, a study reports. Read more  read more →

Researchers at the University of Michigan, Ann Arbor may have found the reason why in prostate cancer metastasis, the body’s own immune system helps the cancer to spread. The findings may lead to new drug targets and therapies. Read more read more →

William Oh, MD, chief, Division of Hematology and Medical Oncology, professor of medicine and urology, Mount Sinai School of Medicine, discusses the management of patients with hormone-sensitive prostate cancer. Read more read more →